retatrutide parkinson's disease clinical trial drug pipeline evolution and future directions | Michael S Okun posted on the topic retatrutide parkinson's disease clinical trial
Description
Johnson & Johnson landed two drugs on the watch listthe bladder cancer medication Rounding out the list are: GSKs Exdensur(depemokimab) for asthma, with $510 million in sales projected in 2031
doi: 10.1038/s41598-017-05815-x
Published 2025 May 30
Morning dosing may also be preferred by individuals who want to monitor for potential side effects during waking hours when they can more easily manage symptoms or seek medical attention if needed
